Margison Geoffrey P, Santibáñez-Koref Mauro F
CRC Carcinogenesis Group, Paterson Institute for Cancer Research, Manchester, UK.
Bioessays. 2002 Mar;24(3):255-66. doi: 10.1002/bies.10063.
The DNA in human cells is continuously undergoing damage as consequences of both endogenous processes and exposure to exogenous agents. The resulting structural changes can be repaired by a number of systems that function to preserve genome integrity. Most pathways are multicomponent, involving incision in the damaged DNA strand and resynthesis using the undamaged strand as a template. In contrast, O(6)-alkylguanine-DNA alkyltransferase is able to act as a single protein that reverses specific types of alkylation damage simply by removing the offending alkyl group, which becomes covalently attached to the protein and inactivates it. The types of damage that ATase repairs are potentially toxic, mutagenic, recombinogenic and clastogenic. They are generated by certain classes of carcinogenic and chemotherapeutic alkylating agents. There is consequently a great deal of interest in this repair system in relation to both carcinogenesis and cancer chemotherapy.
人类细胞中的DNA会因内源性过程和接触外源性因素而不断受到损伤。由此产生的结构变化可通过多种旨在维持基因组完整性的系统进行修复。大多数修复途径由多个组分构成,包括切割受损的DNA链,并以未受损链为模板进行重新合成。相比之下,O(6)-烷基鸟嘌呤-DNA烷基转移酶能够作为一种单一蛋白质发挥作用,它只需去除与蛋白质共价结合并使其失活的有害烷基,就能逆转特定类型的烷基化损伤。烷基转移酶修复的损伤类型具有潜在毒性、致突变性、重组性和染色体断裂性。它们由某些致癌和化疗用烷基化剂产生。因此,该修复系统在致癌作用和癌症化疗方面备受关注。